Literature DB >> 11511166

Kinetic constraints for the thiolysis of 4-methyl-5-(pyrazin-2-yl)-1,2-dithiole-3-thione (oltipraz) and related dithiole-3-thiones in aqueous solution.

K A Carey1, T W Kensler, J C Fishbein.   

Abstract

This report summarizes an investigation of the reactions of biological and other thiols with the cancer chemopreventive oltipraz and other dithiolethiones. Analysis of the kinetics of reaction of 4-methyl-5-(pyrazin-2-yl)-1,2-dithiole-3-thione (oltipraz) 1 with monothiols and dithiols in the range of 0.75-20 mM in aqueous 15% ethanol, at pH 7.5 (0.1 M Tris buffer) and at 37 degrees C has been undertaken. A plot of k(obsd) against [thiol] shows that reactions of mono- and dithiols are first order in thiol concentration. The dependence on pH of these reactions shows that the active species is the thiolate anion. Specific second-order rate constants, k(2) (M(-1) s(-1)) for reaction of the thiolate anions with oltipraz have been determined to be cysteine, 0.040 +/- 0.001; 2-mercaptoethanol, 2.0 +/- 0.02; glutathione, 0.099 +/- 0.001; mercaptoacetic acid anion, 4.0 +/- 0.01; dithiothreitol, 1.33 +/- 0.02; 1,3-propanedithiol, 10 +/- 0.5; 1-mercaptopropane-3-ol, 6.5 +/- 0.1; 1-mercaptopropane-2,3-diol, 1.26 +/- 0.05. A plot of pK(a) against log k(2) for monothiols shows a linear dependence of k(2) on pK(a), beta(nuc) 1.1 +/- 0.07, which accounts for most of the reportedly enhanced reactivity of dithiols over monothiols. The pseudo-first-order rate constant for the solvolysis of oltipraz has been measured as 2.2 (+/-0.2) x 10(-8) s(-1). The kinetics of reaction of three other dithiole-3-thiones with glutathione has also been studied for comparison with oltipraz. The specific second-order rate constants, k(2) (M(-1) s(-1)) are 5-phenyl-1,2-dithiole-3-thione, 4.7 x 10(-)(4); 5-(4-methoxyphenyl)-1,2-dithiole-3-thione, 4.1 x 10(-4); and 1,2-dithiole-3-thione 0.08. Important implications for the mode of biological action of these compounds and the nature of the putative biological targets of the compounds are discussed.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11511166     DOI: 10.1021/tx0100340

Source DB:  PubMed          Journal:  Chem Res Toxicol        ISSN: 0893-228X            Impact factor:   3.739


  6 in total

1.  Inactivation of protein tyrosine phosphatases by oltipraz and other cancer chemopreventive 1,2-dithiole-3-thiones.

Authors:  Sanjib Bhattacharyya; Haiying Zhou; Derrick R Seiner; Kent S Gates
Journal:  Bioorg Med Chem       Date:  2010-06-30       Impact factor: 3.641

2.  1,2-dithiole-3-ones as potent inhibitors of the bacterial 3-ketoacyl acyl carrier protein synthase III (FabH).

Authors:  Xin He; Anne McElwee Reeve; Umesh R Desai; Glen E Kellogg; Kevin A Reynolds
Journal:  Antimicrob Agents Chemother       Date:  2004-08       Impact factor: 5.191

3.  Hydrogen peroxide is a second messenger in phase 2 enzyme induction by cancer chemopreventive dithiolethiones.

Authors:  Ryan Holland; Mettachit Navamal; Murugesan Velayutham; Jay L Zweier; Thomas W Kensler; James C Fishbein
Journal:  Chem Res Toxicol       Date:  2009-08       Impact factor: 3.739

4.  Generation of superoxide from reaction of 3H-1,2-dithiole-3-thione with thiols: implications for dithiolethione chemoprotection.

Authors:  Zhenquan Jia; Hong Zhu; Michael A Trush; Hara P Misra; Yunbo Li
Journal:  Mol Cell Biochem       Date:  2007-09-22       Impact factor: 3.396

5.  Rapid and selective generation of H2S within mitochondria protects against cardiac ischemia-reperfusion injury.

Authors:  Jan Lj Miljkovic; Nils Burger; Justyna M Gawel; John F Mulvey; Abigail A I Norman; Takanori Nishimura; Yoshiyuki Tsujihata; Angela Logan; Olga Sauchanka; Stuart T Caldwell; Jordan L Morris; Tracy A Prime; Stefan Warrington; Julien Prudent; Georgina R Bates; Dunja Aksentijević; Hiran A Prag; Andrew M James; Thomas Krieg; Richard C Hartley; Michael P Murphy
Journal:  Redox Biol       Date:  2022-08-05       Impact factor: 10.787

6.  Thioredoxin glutathione reductase from Schistosoma mansoni: an essential parasite enzyme and a key drug target.

Authors:  Angela N Kuntz; Elisabeth Davioud-Charvet; Ahmed A Sayed; Lindsay L Califf; Jean Dessolin; Elias S J Arnér; David L Williams
Journal:  PLoS Med       Date:  2007-06       Impact factor: 11.069

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.